Blocking Hepatitis C Virus Entry with Snowdrop Lectin
Author Information
Author(s): Ashfaq Usman A, Masoud Muhammad S, Khaliq Saba, Nawaz Zafar, Riazuddin Sheikh
Primary Institution: Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
Can Glanthus Nivalis Agglutinin inhibit the entry of Hepatitis C Virus genotype 3a?
Conclusion
Targeting the HCV glycans is a new approach to develop antiviral drugs against HCV.
Supporting Evidence
- GNA inhibited the infectivity of HCV pseudoparticles in a dose-dependent manner.
- GNA resulted in a 50% reduction of virus at a concentration of 1 ± 2 μg.
- Molecular docking showed that GNA binds to N-linked glycans of HCV glycoproteins.
Takeaway
This study found that a plant protein called GNA can stop the Hepatitis C virus from entering cells, which could help in making new medicines.
Methodology
The study involved producing HCV pseudoparticles and testing the ability of GNA to block HCV entry in liver cells.
Limitations
The study did not explore the long-term effects or resistance development against GNA.
Participant Demographics
Sera from patients chronically infected with HCV, including both male and female patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website